HUMA(HUMA)
HUMA
Q4 2026 EPS Estimate
$-0.09
Nov 6, 2026 · Reports before open
Revenue Estimate
$1M
FY2029E EPS$0.10
FY2030E EPS$0.30
Analyst Sentiment
Wall St. Consensus
Buy11 analysts·Moderate coverage
73
Score
10 Buy (91%)1 Hold (9%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1091%
Hold
19%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$2.00
+263.6%
Consensus
$2.00
+263.6%
Bull
$2.00
+263.6%
12-Month Target Range11 analysts
$2.00$2.00$2.00
Current $0.55Consensus
Current Price
$0.55
Upside to Consensus
$1.45
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+313.95%
EPS—
FY2028
Rev+353.54%
EPS—
FY2029
Rev+94.39%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $6M | $26M | $119M | $232M | $343M |
| Low | $6M | $17M | $54M | $118M | $175M |
| High | $7M | $36M | $200M | $385M | $568M |
| EBITDA Avg | $1M | $5M | $24M | $46M | $69M |
| Low | $1M | $3M | $11M | $24M | $35M |
| High | $1M | $7M | $40M | $77M | $114M |
| EBIT Avg | $-1M | $-5M | $-24M | $-46M | $-69M |
| Low | $-1M | $-7M | $-40M | $-77M | $-114M |
| High | $-1M | $-3M | $-11M | $-24M | $-35M |
| Net Income Avg | $-55M | $-39M | $-17M | $15M | $47M |
| Low | $-59M | $-42M | $-23M | $5M | $17M |
| High | $-51M | $-36M | $18M | $28M | $88M |
| EPS Avg | $-0.34 | $-0.25 | $-0.03 | $0.10 | $0.30 |
| Low | $-0.37 | $-0.27 | $-0.14 | $0.03 | $0.11 |
| High | $-0.32 | $-0.23 | $0.11 | $0.18 | $0.56 |
| Analysts (Rev / EPS) | 4 / 3 | 4 / 3 | 5 / 4 | 2 / 1 | 2 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $2M | $3M | $3M | $4M | $8M | $11M | $34M | $42M |
| Low | $2M | $2M | $2M | $3M | $6M | $8M | $26M | $32M |
| High | $3M | $3M | $4M | $5M | $10M | $14M | $43M | $53M |
| EBITDA Avg | $436,279 | $514,879 | $584,999 | $835,839 | $2M | $2M | $7M | $8M |
| Low | $370,837 | $389,145 | $442,142 | $631,727 | $1M | $2M | $5M | $6M |
| High | $500,043 | $641,928 | $729,351 | $1M | $2M | $3M | $9M | $11M |
| EBIT Avg | $-436,279 | $-514,879 | $-584,999 | $-835,839 | $-2M | $-2M | $-7M | $-8M |
| Low | $-500,043 | $-641,928 | $-729,351 | $-1M | $-2M | $-3M | $-9M | $-11M |
| High | $-370,837 | $-389,145 | $-442,142 | $-631,727 | $-1M | $-2M | $-5M | $-6M |
| Net Income Avg | $-21M | $-20M | $-19M | $-18M | $-16M | $-14M | $866,474 | $4M |
| Low | $-24M | $-27M | $-25M | $-24M | $-21M | $-18M | $591,401 | $3M |
| High | $-18M | $-14M | $-13M | $-12M | $-11M | $-9M | $1M | $6M |
| EPS Avg | $-0.09 | $-0.09 | $-0.08 | $-0.08 | $-0.07 | $-0.06 | $0.00 | $0.02 |
| Low | $-0.10 | $-0.11 | $-0.11 | $-0.10 | $-0.09 | $-0.08 | $0.00 | $0.01 |
| High | $-0.08 | $-0.06 | $-0.05 | $-0.05 | $-0.05 | $-0.04 | $0.00 | $0.02 |
| Analysts (Rev / EPS) | 3 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |